The Van Doorslaer lab @ the University of Arizona

Koenraad Van Doorslaer, PhD.

print

Current and Recent Positions

2016 - Present
Assistant Professor
School of Animal and Comparative Biomedical Sciences
College of Agriculture and Life Sciences
University of Arizona
Tucson, AZ, USA
2016 - Present
Assistant Professor
BIO5 institute
University of Arizona
Tucson, AZ, USA
2016 - 2016
Research Fellow
Lab of Viral Diseases/NIAID/NIH
Bethesda, MD, USA
Dr. A.A. McBride
2011 - 2016
Post-doctoral Fellow
Lab of Viral Diseases/NIAID/NIH
Bethesda, MD, USA
Dr. A.A. McBride
2005 - 2010
Graduate Student
Albert Einstein College of Medicine
Bronx, NY, USA
Dr. R.D. Burk
2004 - 2005
Visiting Scientist
Graham Brown Cancer center
Louisville, Kentucky, USA
Drs. A.B. Jenson and S.J. Ghim
2004 - 2005
Research Associate
Laboratory of Clinical and Epidemiological Virology
Catholic University Leuven, Belgium
Dr. M. Van Ranst

Education

2011
PhD in Biomedical Sciences
Albert Einstein College of Medicine
Thesis: "The evolution of papillomaviral carcinogenicity"
Dr. R.D. Burk
2007
MS in Biomedical Sciences
Albert Einstein College of Medicine
Dr. R.D. Burk
2004
MS in Biomedical Sciences
Catholic University Leuven
Thesis: "Genetic characterisation of the Procyon lotor papillomavirus type 1"
Graduated Magna cum Laude
Dr. M. Van Ranst
2002
BS in Biomedical Sciences
Catholic University Leuven

Courses and Workshops

2014
NIH FAES Next Generation Sequencing analysis
National Institutes of Health, Bethesda, MD, USA
2009
Workshop on Molecular Evolution
Marine Biology Laboratories, Woodshole, MA, USA
2004
Computational Genomics workshop
Charles University Prague, the Czech Republic

Mentoring

Graduate students
Name of Student Current Position
Ariana Harari, PhDScientific Associate at IMsci

Professional Memberships, Fellowships and Honors

  • Recipient of 2014 Travel Award to attend the 3rd ASM Conference on Viral Manipulation of Nuclear Processes
  • Member of the International Committee for the Nomenclature of Viruses (ICTV) papillomavirus study group
  • Recipient of 2010 "student service award", Albert Einstein College of Medicine
  • Recipient of 2009 International Papillomavirus Society travel grant
  • Recipient of 2007 International Papillomavirus Society travel grant
  • Recipient of 2006 International Papillomavirus Society travel grant
  • Fellow of the Belgian American Educational Foundation (BAEF)

Publications

Peer reviewed Articles and Reviews
h-index: 20
  1. Novel recombinant papillomavirus genomes expressing selectable genes.. Van Doorslaer K, Porter S, McKinney C, Stepp WH, McBride AA. Sci Rep. 2016 Nov 28;6:37782. doi: 10.1038/srep37782. Pubmed
  2. Detection and genotyping of Alpha Human Papillomaviruses from archival formalin fixed tissue samples. Van Doorslaer K, Chen Z, and McBride AA. Curr Protoc Microbiol. 2016 Nov 18;43:14B.9.1-14B.9.20. doi: 10.1002/cpmc.16. Pubmed
  3. The Papillomavirus Episteme: a major update to the papillomavirus sequence database. Van Doorslaer K, Li Z, Xirasagar S, Maes P, Kaminsky D, Liou D, Sun Q, Kaur R, Huyen Y, McBride AA. Nucleic Acids Res. 2017 Jan; doi: 10.1093/nar/gkw879. Epub 2016 Oct 5. NAR website
  4. Molecular archeological evidence in support of the repeated loss of a papillomavirus gene. Van Doorslaer K and McBride AA. Sci Rep. 2016 Sep 8;6:33028. doi: 10.1038/srep33028. Pubmed
  5. The Ancient Evolutionary History of Polyomaviruses. Buck CB, Van Doorslaer K, Peretti A, An P, Katz J, Pipas J, McBride AA, Camus A, McDermott A, Dill J, Delwart E, Ng TFN, Farkas K, Austin C, Kraberger S, Davison W, Pastrana D and Varsani A. PLoS Pathog. 2016 Apr 19;12(4):e1005574. doi: 10.1371/journal.ppat.1005574. eCollection 2016 Apr. Pubmed
  6. Papillomavirus Evolution Driven by the Host Restriction Factor APOBEC3 and DNA Methylation. Van Doorslaer K, Warren CJ, Pandey A, Espinosa JM, Dohun P.Virus Evol 2015 1 (1): vev015 DOI: Pubmed
  7. UbSRD: The Ubiquitin Structural Relational Database. Harrison JS, Jacobs TM, Houlihan K, Van Doorslaer K and Kuhlman B. J Mol Biol. 2015 Sep 18. pii: S0022-2836(15)00522-7. doi: 10.1016/j.jmb.2015.09.011. Pubmed
  8. Degradation of human PDZ-proteins by human Alphapapillomaviruses represents an evolutionary adaptation to a novel cellular niche. Van Doorslaer K, DeSalle R, Einstein MH and Burk RD. PLoS Pathog. 2015 Jun 18;11(6):e1004980. doi: 10.1371/journal.ppat.1004980. eCollection 2015 Jun. Pubmed
  9. A Proteomic approach to discover and compare interacting partners of Papillomavirus E2 proteins from diverse phylogenetic groups. Jang MK, Anderson DE, Van Doorslaer K and McBride AA. Proteomics. 2015 Mar 11. doi: 10.1002/pmic.201400613. Pubmed
  10. Evolution of the Papillomaviridae. Van Doorslaer K. Virology. 2013 Oct;445(1-2):11-20. doi: 10.1016/j.virol.2013.05.012. Epub 2013 Jun 14. Pubmed
  11. Condylomatous genital lesions in cynomolgus macaques from Mauritius. Harari A, Wood CE, Van Doorslaer K, Chen Z, Domaingue MC, Elmore D, Koenig P, Wagner JD, Jennings RN and Burk RD. Toxicol Pathol. 2013 Aug;41(6):893-901. doi: 10.1177/0192623312467521. Epub 2012 Dec 21. Pubmed
  12. The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis. Van Doorslaer K, Tan Q, Xirasagar S, Bandaru S, Gopalan V, Mohamoud Y, Huyen Y and McBride AA. Nucleic Acids Res. 2013 Jan;41(Database issue):D571-8. doi: 10.1093/nar/gks984. Epub 2012 Oct 23. Pubmed
  13. Association between hTERT activation by HPV E6 proteins and oncogenic risk. Van Doorslaer K and Burk RD. Virology. 2012 Nov 10;433(1):216-9. doi: 10.1016/j.virol.2012.08.006. Epub 2012 Aug 25. Pubmed
  14. Sequence imputation of HPV16 genomes for genetic association studies. Smith B, Chen Z, Reimers L, Van Doorslaer K, Schiffman M, Desalle R, Herrero R, Yu K, Wacholder S, Wang Tand Burk RD. PLoS One. 2011;6(6):e21375. doi: 10.1371/journal.pone.0021375. Epub 2011 Jun 23. Pubmed
  15. Papillomaviruses: evolution, Linnaean taxonomy and current nomenclature. Van Doorslaer K, Bernard HU, Chen Z, de Villiers EM, zur Hausen H and Burk RD. Trends Microbiol. 2011 Feb;19(2):49-50; author reply 50-1. doi: 10.1016/j.tim.2010.11.004. Epub 2010 Dec 7. Pubmed
  16. Evolution of human papillomavirus carcinogenicity. Van Doorslaer K and Burk RD. Adv Virus Res. 2010;77:41-62. doi: 10.1016/B978-0-12-385034-8.00002-8. Review. Pubmed
  17. Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. Fu L, Van Doorslaer K, Chen Z, Ristriani T, Masson M, Travé G and Burk RD. PLoS One. 2010 Sep 17;5(9). doi:pii: e12816. 10.1371/journal.pone.0012816. Pubmed
  18. Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB. Connolly EC, Van Doorslaer K, Rogler LE and Rogler CE. Mol Cancer Res. 2010 May;8(5):691-700. doi: 10.1158/1541-7786.MCR-09-0465. Epub 2010 May 11. Pubmed
  19. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Bernard HU, Burk RD, Chen Z, Van Doorslaer K, zur Hausen H and de Villiers EM. Virology. 2010 May 25;401(1):70-9. doi: 10.1016/j.virol.2010.02.002. Epub 2010 Mar 5. Pubmed
  20. Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties. Safaeian M, Van Doorslaer K, Schiffman M, Chen Z, Rodriguez AC, Herrero R, Hildesheim A and Burk RD. Arch Virol. 2010 Mar;155(3):367-70. doi: 10.1007/s00705-009-0579-2. Epub 2010 Jan 6. Pubmed
  21. Genomic diversity and interspecies host infection of alpha12 Macaca fascicularis papillomaviruses (MfPVs). Chen Z, Van Doorslaer K, DeSalle R, Wood CE, Kaplan JR, Wagner JD and Burk RD. Virology. 2009 Oct 25;393(2):304-10. doi: 10.1016/j.virol.2009.07.012. Epub 2009 Aug 28. Pubmed
  22. Human papillomaviruses: genetic basis of carcinogenicity. Burk RD, Chen Z and Van Doorslaer K. Public Health Genomics. 2009;12(5-6):281-90. doi: 10.1159/000214919. Epub 2009 Aug 11. Review. Pubmed
  23. Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia. Van Doorslaer K, Reimers LL, Studentsov YY, Einstein MH and Burk RD. Gynecol Oncol. 2010 Feb;116(2):208-12. doi: 10.1016/j.ygyno.2009.05.044. Epub 2009 Jun 24. Pubmed
  24. Identification of unusual E6 and E7 proteins within avian papillomaviruses: cellular localization, biophysical characterization, and phylogenetic analysis. Van Doorslaer K, Sidi AO, Zanier K, Rybin V, Deryckère F, Rector A, Burk RD, Lienau EK and Van Ranst M, Travé G. J Virol. 2009 Sep;83(17):8759-70. doi: 10.1128/JVI.01777-08. Epub 2009 Jun 24. Pubmed
  25. Macaca fascicularis papillomavirus type 1: a non-human primate betapapillomavirus causing rapidly progressive hand and foot papillomatosis. Joh J, Hopper K, Van Doorslaer K, Sundberg JP, Jenson AB and Ghim SJ. J Gen Virol. 2009 Apr;90(Pt 4):987-94. doi: 10.1099/vir.0.006544-0. Epub 2009 Mar 4. Pubmed
  26. A single amino acid substitution in a segment of the CA protein within Gag that has similarity to human immunodeficiency virus type 1 blocks infectivity of a human endogenous retrovirus K provirus in the human genome. Heslin DJ, Murcia P, Arnaud F, Van Doorslaer K, Palmarini M and Lenz J. J Virol. 2009 Jan;83(2):1105-14. doi: 10.1128/JVI.01439-08. Epub 2008 Nov 12. Pubmed
  27. Genomic characterization of two novel reptilian papillomaviruses, Chelonia mydas papillomavirus 1 and Caretta caretta papillomavirus 1. Herbst LH, Lenz J, Van Doorslaer K, Chen Z, Stacy BA, Wellehan JF Jr, Manire CA and Burk RD. Virology. 2009 Jan 5;383(1):131-5. doi: 10.1016/j.virol.2008.09.022. Epub 2008 Oct 29.Pubmed
  28. Genomic characterization of novel dolphin papillomaviruses provides indications for recombination within the Papillomaviridae. Rector A, Stevens H, Lacave G, Lemey P, Mostmans S, Salbany A, Vos M, Van Doorslaer K, Ghim SJ, Rehtanz M, Bossart GD, Jenson AB and Van Ranst M. Virology. 2008 Aug 15;378(1):151-61. doi: 10.1016/j.virol.2008.05.020. Epub 2008 Jun 24. Pubmed
  29. Ancient papillomavirus-host co-speciation in Felidae. Rector A, Lemey P, Tachezy R, Mostmans S, Ghim SJ, Van Doorslaer K, Roelke M, Bush M, Montali RJ, Joslin J, Burk RD, Jenson AB, Sundberg JP, Shapiro B and Van Ranst M. Genome Biol. 2007;8(4):R57. Pubmed
  30. Complete genomic characterization of a murine papillomavirus isolated from papillomatous lesions of a European harvest mouse (Micromys minutus). Van Doorslaer K, Rector A, Jenson AB, Sundberg JP, Van Ranst M and Ghim SJ. J Gen Virol. 2007 May;88(Pt 5):1484-8. Pubmed
  31. Genetic characterization of the first chiropteran papillomavirus, isolated from a basosquamous carcinoma in an Egyptian fruit bat: the Rousettus aegyptiacus papillomavirus type 1. Rector A, Mostmans S, Van Doorslaer K, McKnight CA, Maes RK, Wise AG, Kiupel M and Van Ranst M. Vet Microbiol. 2006 Oct 31;117(2-4):267-75. Epub 2006 Jul 18. Pubmed
  32. Genetic characterization of the Capra hircus papillomavirus: a novel close-to-root artiodactyl papillomavirus. Van Doorslaer K, Rector A, Vos P and Van Ranst M. Virus Res. 2006 Jun;118(1-2):164-9. Epub 2006 Jan 23. Pubmed
  33. Isolation and cloning of the raccoon (Procyon lotor) papillomavirus type 1 by using degenerate papillomavirus-specific primers. Rector A, Van Doorslaer K, Bertelsen M, Barker IK, Olberg RA, Lemey P, Sundberg JP and Van Ranst M. J Gen Virol. 2005 Jul;86(Pt 7):2029-33. Pubmed
  34. Isolation and cloning of a papillomavirus from a North American porcupine by using multiply primed rolling-circle amplification: the Erethizon dorsatum papillomavirus type 1. Rector A, Tachezy R, Van Doorslaer K, MacNamara T, Burk RD, Sundberg JP and Van Ranst M. Virology. 2005 Jan 20;331(2):449-56. Pubmed
Book Chapters
  1. Recent developments in the interactions between caveolin and pathogens. Machado FS, Rodriquez NE, Adesse D, Garzoni LR, Esper L, Lisanti MP, Burk RD, Albanese C, Van Doorslaer K., Weiss LM, Nagajyothi F, Nosanchuk JD, Wilson ME, Tanowitz HB. 2010. In Caveolins and caveolae: Role in signaling and Disease mechanisms. Edited by Jasmin JF, Frank PG and Lisanti MP. Landes Bioscience. Pubmed
  2. Replication and Maintenance of Viral Genomes by Association with Host Chromatin. Van Doorslaer K., Sekhar V, Khan J, McBride AA. 2010. In Small DNA Viruses. Edited by Kevin L. Gaston. Horizon Press.
General Public literature
  1. PaVE; the papillomavirus episteme, McBride AA and Van Doorslaer K, HPV today (number 26).
Invited Lectures
  1. University of Arizona, Tucson, AZ, USA, 2016.
  2. Plenary talk at 30th International Papillomavirus Conference, Lisbon, Portugal, 2015.
  3. "Taxonomy workshop" at 30th International Papillomavirus Conference, Lisbon, Portugal, 2015.
  4. University of Western Ontario, Ontario, Canada, 2015
  5. Comparative Biomedical Science Day symposium, National Institutes of Health, Bethesda, MD, USA, 2014.
  6. Octet User meeting, Bethesda, MD, USA, 2013.
  7. "PaVE Breakfast session" at 28th International Papillomavirus Conference, San Juan, Puerto Rico, 2012.
  8. Ecole Supérieure de Biotechnologies de Strasbourg, Strasbourg, France, 2009.
  9. Presentation at Microbial Evolution & Genomics NYC Area Symposium, 2008.
Abstracts submitted to (international) conferences
    (*) Oral presentation
  1. Viral transcriptional enhancer is required for optimal persistence of an oncogenic papillomavirus genome., Van Doorslaer K, Chapman S, Khan J, McBride AA., DNA Tumor Virus Meeting , Montreal, Canada, 2016*.
  2. Molecular archeological evidence in support of the repeated loss of a papillomavirus gene., Van Doorslaer K, McBride AA., DNA Tumor Virus Meeting , Montreal, Canada, 2016*.
  3. HPV genotypes in genital dysplasia and carcinoma in GATA2 deficiency., Pichard DC, Van Doorslaer K, McBride AA, Zerbe CS, Stratton P, Holland SM, Kong HH, Cowen EW., Society for Investigative Dermatology 75thAnnual Meeting, Scottsdale, AZ, USA, 2016.
  4. Optimal persistence of an oncogenic papillomavirus genome requires the viral transcriptional enhancer., Van Doorslaer K, Chapman S, Khan J, McBride AA., ICGEB DNA tumour virus meeting, Trieste, Italy, 2015*.
  5. Roles of APOBEC3 Cytidine Deaminases on Papillomavirus Restriction and Evolution., Warren CJ, Xu T, Van Doorslaer K, Westrich JA, Guo K, Griffin LM, Lee D, Lambert PF, Santiago ML, Pyeon D., ICGEB DNA tumour virus meeting, Trieste, Italy, 2015.
  6. The Ancient Evolutionary History of Polyomaviruses., Buck C, Peretti A, An P, Katz J, Pipas J, Van Doorslaer K, McBride AA, Camus A, McDermott A, Delwart E, Ng T, Farkas K, Austin C, Kraberger S, Davison W, Pastrana D., ICGEB DNA tumour virus meeting, Trieste, Italy, 2015.
  7. Fish Papillomaviruses., Van Doorslaer K, Peretti A, McBride AA, Pastrana DV, Buck CB., ICGEB DNA tumour virus meeting, Trieste, Italy, 2015*.
  8. UBSRD: The Ubiquitin Structural Relational Database., Harrison JS, Houlihan K, Jacobs TM, Van Doorslaer K, Kuhlman B., RosettaCon 2014, Leavenworth, USA, 2014.
  9. Degradation of human PDZ-proteins by human Alphapapillomaviruses represents an evolutionary adaptation., Van Doorslaer K, DeSalle R, Burk RD., 29th International Papillomavirus conference, Seattle, USA, 2014*.
  10. Use of a complementation assay to determine the minimal requirements for long-term maintenance of a High-Risk papillomavirus genome., Van Doorslaer K, Khan J, Chapman S, McBride AA., 29th International Papillomavirus conference, Seattle, USA, 2014.
  11. Use of a complementation assay to determine the minimal requirements for long-term maintenance of a High-Risk papillomavirus genome., Van Doorslaer K, Khan J, Chapman S, McBride AA., DNA tumour virus meeting, Madison, WI, USA, 2014*.
  12. Use of a complementation assay to determine the minimal requirements for long-term maintenance of a High-Risk papillomavirus genome., Van Doorslaer K, Khan J, Chapman S, McBride AA., DNA tumour virus meeting, Birmingham, UK, 2013*.
  13. The papillomavirus Episteme (PaVE)., Van Doorslaer K, Tan Q, Xirasagar S, Maes P, Huyen Y, McBride AA., 28th International Papillomavirus Conference, San Juan, Puerto Rico, 2012*. YouTube
  14. The papillomavirus Episteme (PaVE)., Van Doorslaer K, Tan Q, Xirasagar S, Maes P, Huyen Y, McBride AA., DNA tumour virus meeting, Montreal, Canada, 2012*.
  15. Conservation of a tri-peptide implicated in tethering of viral genomes to host chromosomes., Van Doorslaer K, McBride AA., ICGEB DNA tumour virus meeting, Trieste, Italy, 2011*.
  16. Structural evolution of papillomavirus E6 and E7 oncoproteins., Charbonnier S, Van Doorslaer K, McEwen A, Ould Sidi A, Zanier K, Muller I, Poussin P, Kohler K, Ramirez J, Vande Pol S, Cavarelli L, Travé G., ICGEB DNA tumour virus meeting, Trieste, Italy, 2011.
  17. Activation of the hTERT promoter by alpha HPV E6 proteins is associated with oncogenic risk., Van Doorslaer K, Burk RD., 26th International Papillomavirus Conference and Clinical Workshop, Montreal, Canada, 2010*.
  18. Imputation of HPV16 Complete Genome Sequences and Epidemiological Analysis., Smith B, Reimers L, Chen Z, Van Doorslaer K, Schiffman M, Herrero R, Burk RD., 26th International Papillomavirus Conference and Clinical Workshop, Montreal, Canada, 2010.
  19. Novel monkey betapapillomavirus associated with hand and foot papillomas., Wood C, Tannehill-Gregg S, Chen Z, Van Doorslaer K, Cline M, Burk RD., 26th International Papillomavirus Conference and Clinical Workshop, Montreal, Canada, 2010*.
  20. HPV complete genome sequence imputation from partial sequence information., Smith B, Chen Z, Van Doorslaer K, Schiffman M, Burk RD., 26th International Papillomavirus Conference and Clinical Workshop, Montreal, Canada, 2010.
  21. Characterizations of nine Macaca fascicularis papillomavirus complete genomes., Van Doorslaer K, Chen Z, Wood S, Burk RD., 25th International Papillomavirus Conference and Clinical Workshop, Malmo, Sweden, 2009*.
  22. Evolution of primate alpha papillomaviruses., Chen Z, Van Doorslaer K, DeSalle R, Wood C, Burk RD., 25th International Papillomavirus Conference and Clinical Workshop, Malmo, Sweden, 2009.
  23. Serological response to an HPV16 E7 Based therapeutic vaccine., Van Doorslaer K, Reimers L, Studentsov YY, Einstein M, Burk RD., 26th International Papillomavirus Conference and Clinical Workshop, Malmo, Sweden, 2009.
  24. Lack of heterogeneity of HPV16-E7 compared with HPV31 and HPV73 E7., Van Doorslaer K, Schiffman M, Rodriguez A, Herrero R, Burk RD., 25th International Papillomavirus Conference and Clinical Workshop, Malmo, Sweden, 2009.
  25. Biochemical and biophysical and phylogenetic characterization of a novel onco-protein E6 derived from Avian Papillomaviruses., Van Doorslaer K, Sidi A, Lienau EK, Rector A, Travé G, Burk RD, Van Ranst M., 24th International Papillomavirus Conference and Clinical Workshop, Beijing, China, 2007*.
  26. Degradation of pRb by the HPV E7 proteins could be tightly associated with oncogenicity., Van Doorslaer K, Fu L, Burk RD., 25th International Papillomavirus Conference and Clinical Workshop, Beijing, China, 2007.
  27. Biochemical and biophysical characterisation of the N-terminal domain of HPV16 E6 and a novel oncoprotein E6 from the Avian Papillomaviruses., Sidi A, Zanier K, Charbonnier S, Van Ranst M, Van Doorslaer K, Travé G., EMBO meeting, Trieste, Italy, 2007.
  28. Genomic characterization of three novel dolphin papillomaviruses provides indications for putative recombination within the Papillomaviridae., Rector A, Rehtanz M, Lacave G, Mostmans S, Salbany A, Stevens H, Van Doorslaer K, Ghim SJ, Bossart GD, Jenson A B, Van Ranst M., 23rd International Papillomavirus Conference and Clinical Workshop, Prague, The Czech Republic, 2006.
  29. Genetic characterization of the Rousettus aegyptiacus papillomavirus type 1, isolated from a basosquamous carcinoma in an Egyptian fruit bat., Rector A, Mostmans S, Van Doorslaer K, McKnight CA, Maes RK, Wise A G, Kiupel M, Van Ranst M., 23rd International Papillomavirus Conference and Clinical Workshop, Prague, The Czech Republic, 2006.
  30. Genetic characterization of a novel close-to-root papillomavirus in a bottlenose dolphin: Tursiops truncatus papillomavirus type 1 (TtPV-1)., Rector A, Lacave G, Mostmans S, Van Doorslaer K, Rehtanz M, Salbany A, Ghim SJ, Jenson AB, Van Ranst M., European Association for Aquatic Mammals (EAAM) conference, Riccione, Italy, 2006.
  31. Genetic characterization of a novel close-to-root papillomavirus in a bottlenose dolphin: Tursiops truncatus papillomavirus type 1 (TtPV-1)., Rector A, Lacave G, Mostmans S, Van Doorslaer K, Rehtanz M, Salbany A, Ghim SJ, Jenson AB, Van Ranst M., Dolphin Neonatal and Reproduction Symposium, Indianapolis, USA, 2005.
  32. Genetic Characterization of a Novel Artiodactyl Papillomavirus: The Capra hircus Papillomavirus., Van Doorslaer K, Rector A, Van Ranst M., 22nd International Papillomavirus Conference, Vancouver, Canada, 2005.
  33. Isolation and Cloning of the Raccoon (Procyon lotor) Papillomavirus Type 1 by Using Degenerate Papillomavirus-Specific Primers., Rector A, Van Doorslaer K, Bertelsen M, Barker IK, Olberg RA, Lemey P, Sundberg JP, Van Ranst M., 22nd International Papillomavirus Conference, Vancouver, Canada, 2005.
  34. Isolation and Cloning of the raccoon (Procyon lotor) Papillomavirus Type 1 by Using Degenerate Papillomavirus-Specific Primers., Rector A, Van Doorslaer K, Sundberg JP, Bertelsen M, Barker IK, Olberg RA, Van Ranst M., 8th Annual Meeting of the European Society for Clinical Virology, Geneva, Switzerland, 2004.
  35. The genetic characterisation of the Capra hircus papillomavirus, a novel close to root artiodactyl papillomavirus., Van Doorslaer K, Rector A, Van Ranst M., 8th Annual Meeting of the European Society for Clinical Virology, Geneva, Switzerland, 2004.
  36. Genetic characterisation of the Procyon lotor papillomavirus type 1 (PlPV-1) genome., Van Doorslaer K, Rector A, Van Ranst M., 8th MMSRC, Maastricht, The Netherlands, 2004*.